Alastair Monty

Alastair Monty

Alastair is the founder and CEO of Mendea Technologies. After stepping away from corporate law, he became interested in meditation and neuromodulation research, connecting directly with scientists before founding a company focused on improving how the mind works. 

The starting conviction from meditation was simple: if the mind works better, life is better. Alastair chose OCD, a condition affecting over 750,000 people in the UK, where about half of patients don't get relief from medication and therapy. 

Alastair wants to use focused ultrasound - concentrated soundwaves which can change neural behaviour when focused onto precise points - to calm overactive circuits in OCD patients' brains. A patient would wear a lightweight headset in a clinic during a therapy session, with real-time brain monitoring personalising the treatment. 

As Frontier Fellow, hosted by the Babraham Research Campus, Alastair will explore: Combined EEG and FUS for severe OCD